FindTrial
Sign In

COMPARISON OF SPINAL ANAESTHESIA WITH HYPERBARIC LEVOBUPIVACAINE AND HYPERBARIC BUPIVACAINE WITH FENTANYL AS ADDITIVE DRUG IN ELECTIVE CESAREAN SECTIONS

COMPARISON OF SPINAL ANAESTHESIA WITH HYPERBARIC LEVOBUPIVACAINE WITH FENTANYL AND HYPERBARIC BUPIVACAINE WITH FENTANYL IN ELECTIVE CESAREAN SECTIONS

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/03/050728
Enrollment
130
Registered
2023-03-15
Start date
Unknown
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Levobupivacaine: A local anaesthetic agent used in spinal anasethesia.It is a enantiomer of bupivacaine. Route:Intrathecal dose :10mg levobupivacaine with 25mcg fentanyl Control Interve

Sponsors

Shri B M Patil medicaal college hospital and Reaseach centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Women more than 37 weeks period of gestation ASA GRADE 1 AND 2 Scheduled for elective cesarean sections

Exclusion criteria

Exclusion criteria: Having contraindications to regional anesthesia Body weight more than 100kg Shorter than 150cm Taller than 175cm Having systemic diseases Expected mothers with foetal anomaly,placenta previa,abruptio placenta.

Design outcomes

Primary

MeasureTime frame
To assess the and compare the sensory,motor block characteristics and hemodynamic changes with hyperbaric bupivacaine and levobupivacaine in 24 hrs after administartion of the drug. To assess the prolongation of block when fentanyl is used.Timepoint: 24 hours—

Secondary

MeasureTime frame
To assess the side effects like cardiotoxicity and neurotoxicity associated with levobupivacaine and bupivacaine.Timepoint: 24 hours—

Countries

India

Contacts

Public ContactSINCHANA A S

Shri B M Ptil medical college

drvijay8@gmail.com9844095250

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026